Lumigan 0.03% Eye Drop Information
Lumigan 0.03% Eye Drop is a prescription medicine that is available as a Drops. Glaucoma are some of its major therapeutic uses.
The optimal dosage of Lumigan 0.03% Eye Drop is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Lumigan 0.03% Eye Drop include Eye itching, Eye irritation, Eye Burning. While these are the most often observed Lumigan 0.03% Eye Drop side effects, there are can be others also. These have been listed below. Usually, these side effects of Lumigan 0.03% Eye Drop go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Lumigan 0.03% Eye Drop is Unknown for pregnant women and Unknown for women who are breastfeeding. Warnings related to Lumigan 0.03% Eye Drop's effects on the liver, heart and kidney, if any, have been listed below.
The section on Lumigan 0.03% Eye Drop contraindications lists all such conditions.
Additionally, Lumigan 0.03% Eye Drop may also adversely react with other medicines. See below for a complete list.
You should also be aware that Lumigan 0.03% Eye Drop is safe while driving, and is addiction.
Lumigan 0.03% Eye Drop Benefits & Uses
Lumigan 0.03% Eye Drop is used to treat the following -
Other Benefits
Lumigan 0.03% Eye Drop Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Lumigan 0.03% Eye Drop Side Effects
Based on research, the following side effects have been observed when Lumigan 0.03% Eye Drop is used -
Common
- Eye itching
- Eye irritation
- Eye Burning
Lumigan 0.03% Eye Drop Related Warnings
-
Is the use of Lumigan 0.03% Eye Drop safe for pregnant women?
The effects of Lumigan on pregnant women are unknown since no research has been done to ascertain it yet.
Unknown -
Is the use of Lumigan 0.03% Eye Drop safe during breastfeeding?
In the absence of any scientific study about the side effects of Lumigan in breastfeeding women, information on safety of Lumigan is unavailable.
Unknown -
What is the effect of Lumigan 0.03% Eye Drop on the Kidneys?
Lumigan is not harmful for kidneys.
Safe -
What is the effect of Lumigan 0.03% Eye Drop on the Liver?
There are no any side effects of Lumigan on the liver.
Safe -
What is the effect of Lumigan 0.03% Eye Drop on the Heart?
Using Lumigan does not have any harmful effects on the heart.
Safe
Severe Interaction of Lumigan 0.03% Eye Drop with Other Drugs
Lumigan 0.03% Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Lumigan 0.03% Eye Drop Contraindications
If you are suffering from any of the following diseases, you should not take Lumigan 0.03% Eye Drop unless your doctor advises you to do so -
- Uveitis
- Corneal Abrasion
- Kidney Disease
- Liver Disease
Frequently asked Questions about Lumigan 0.03% Eye Drop
-
Is this Lumigan 0.03% Eye Drop habit forming or addictive?
Lumigan 0.03% Eye Drop is not addictive in nature.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Lumigan 0.03% Eye Drop as it does not make you drowsy.
Safe -
Is it safe?
Yes, Lumigan 0.03% Eye Drop does not show any kind of adverse effect.
Safe -
Is it able to treat mental disorders?
No, the use of Lumigan 0.03% Eye Drop in mental disorders is not effective.
No
Lumigan 0.03% Eye Drop Interactions with Food and Alcohol
-
Interaction between Food and Lumigan 0.03% Eye Drop
Taking Lumigan 0.03% Eye Drop with food is safe.
Safe -
Interaction between Alcohol and Lumigan 0.03% Eye Drop
Information about the interaction of Lumigan 0.03% Eye Drop and alcohol is not currently available because this topic has not been researched yet.
Unknown
See all substitutes for Lumigan
- Careprost Eye Drop - ₹482
- Lumigan 0.01% Eye Drop - ₹656
- Bimat LS Eye Drop - ₹203
- Lowprost Eye Drop - ₹266
- Lumigan 0.03% Eye Drop - ₹719
- Bimapix Eye Drop - ₹140
- Bimaday Eye Drop - ₹245
- Bimat Eye Drop - ₹281
- Careprost LS 0.01% Eye Drop 3ml - ₹379
- Gloria Eye Drop - ₹519
- Intaprost Eye Drop - ₹360
- Nuprost 0.03% Eye Drop - ₹292
- Xyprost Eye Drop - ₹265
- Bimatoprost Eye Drop - ₹210
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 227-228
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lumigan® (bimatoprost)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Latisse® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bimatoprost Sandoz® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lumigan® Pf (bimatoprost)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 227-228
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lumigan® (bimatoprost)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Latisse® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bimatoprost Sandoz® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lumigan® Pf (bimatoprost)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 227-228
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lumigan® (bimatoprost)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Latisse® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bimatoprost Sandoz® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lumigan® Pf (bimatoprost)
